Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: Enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotide

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 11, 1999, Pages 2689-2696

  Prasad, Vikram ^a   Hashim, Shehla ^a   Mukhopadhyay, Amitabha ^a   Basu, Sandip K ^a   Roy, Rajendra P ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; POLYGUANYLIC ACID; SCAVENGER RECEPTOR;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; MACROPHAGE; MODEL; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR BINDING; VESICULAR STOMATITIS VIRUS; VIRUS INHIBITION;

EID: 0032708654     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.11.2689     Document Type: Article

References (52)

1. Abraham, R., N. Singh, A. Mukhopadhyay, S. K. Basu, V. Bal, and S. Rath. 1995. Modulation of immunogenicity and antigenicity of proteins by maleylation to target scavenger receptor on macrophages. J. Immunol. 154:1-8.
2. Agrawal, S. 1992. Antisense oligonucleotides as antiviral agents. Trends Biotechnol. 10:152-157.
3. Agris, C. H., K. R. Blake, P. S. Miller, M. P. Reddy, and P. O. P. T'so. 1986. Inhibition of vesicular stomatitis virus protein synthesis and infection by sequence specific oligodeoxyribonucleoside methylphosphonates. Biochemistry 25:6268-6275.
4. Basu, S. K. 1990. Receptor mediated endocytosis of macromolecular conjugates in selective drug delivery. Biochem. Pharmacol. 40:1941-1946.
5. Beltinger, C., H. U. Saragovi, R. M. Smith, L. LeSauteur, N. Shah, L. DeDionisio, L. Christensen, A. Raible, L. Jarett, and A. M. Gerwitz. 1995. Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J. Clin. Investig. 95:1814-1823.
6. Benimatskaya, L., J. D. Loike, Z. Khaled, G. Loike, S. C. Silverstein, L. Cao, J. el Khoury, T. Q. Cai, and C. A. Stein. 1997. Mac-1 (CDl1b/CD18) is an oligodeoxynucleotide-binding protein. Nat. Med. 3:414-420.
7. Benimetskaya, L., M. Berton, A. Kolbanovskj, S. Benimetsky, and C. A. Stein. 1997. Formation of a G-tetrad and higher order structures correlates with biological activity of the Re1A (NF-kB p65) 'antisense' oligodeoxynucleotide. Nucleic Acids Res. 25:2648-2656.
8. Biessen, E. A., H. Vietsch, J. Kuiper, M. K. Bijsterbosch, and T. J. van Berkel. 1998. Liver uptake by phosphodiester oligodeoxynucleotides is mediated by scavenger receptor. Mol. Pharmacol. 53:262-269.
9. Bongartz, J. P., A. M. Aubertin, P. G. Milhaud, and B. Lebleu. 1994. Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide. Nucleic Acids Res. 22:4681-4688.
10. Brown, D. A., S. H. Kang, S. M. Gryaznov, L. DeDionisio, O. Heidenreich, S. Sullivan, X. Xu, and M. I. Nerenberg. 1994. Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J. Biol. Chem. 269:26801-26805.
11. Brown, M. S., S. K. Basu, J. R. Falck, Y. K. Ho, and J. L. Goldstein. 1980. The scavenger cell pathway for protein degradation: specificity of the binding site that mediates the uptake of negatively charged LDL by macrophages. J. Supramol. Struct. 13:67-81.
12. Burgess, T., E. F. Fischer, S. L. Ross, J. V. Brady, Y. Quin, L. A. Bayewitch, A. M. Cohen, C. J. Herrera, S. S. Hu, T. B. Kramer, F. D. Loll, F. H. Martin, G. F. Pierce, L. Simonet, and C. L. Ferrell. 1995. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. Natl. Acad. Sci. USA 92:4051-4055.
13. Butler, P. J. G., and B. S. Hartley. 1972. Maleylation of amino groups. Methods Enzymol. 25:191.
14. Chaudhury, G. 1997. Scavenger receptor-mediated delivery of antisense mini-exon phosphorothioate oligonucleotides to leishmania-infected macrophages: selective and efficient elimination of the parasite. Biochem. Pharmacol. 53:385-391.
15. Deshpande, D., D. Toledo-Velasquez, D. Thakkar, W. Liang, and Y. Rojanasakul. 1996. Enhanced cellular uptake of oligonucleotides by EGF receptor-mediated endocytosis in A549 cells. Pharm. Res. 13:57-61.
16. Gao, W. Y., F. S. Han, C. Storm, W. Egan, and Y. C. Cheng. 1992. Phosphorothioate oligodeoxynucleotides are inhibitors of DNA polymerases and RNase H: implications for antisense technology. Mol. Pharmacol. 41:223-229.
17. Gewirtz, A. M., C. A. Stein, and P. M. Glazer. 1996. Facilitating oligonucleotide delivery: helping antisense deliver on its promise. Proc. Natl. Acad. Sci. USA 93:3161-3163.
18. Goldstein, J. L., Y. K. Ho, S. K. Basu, and M. S. Brown. 1979. Stimulation of cholestryl ester synthesis in macrophages by extract of atherosclerotic human aortas and complexes of albumin/cholestryl esters. Proc. Natl. Acad. Sci. USA 76:333-337.
19. Goldstein, J. L., S. K. Basu, and M. S. Brown. 1983. Receptor mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 98:241-260.
20. Guo, Q., M. Lu, M. A. Marky, and N. R. Kallenbach. 1992. Interaction of dye ethidium bromide with DNA containing guanine repeats. Biochemistry 31: 2451-2455.
21. Guvakova, M. A., L. A. Yakubov, I. Vlodavjky, J. L. Tonkinson, and C. A. Stein. 1995. Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors and remove it from low affinity binding sites on extracellular matrix. J. Biol. Chem. 270:2620-2627.
22. Hardin, C. C., E. Henderson, T. Watson, and J. K. Prosser. 1991. Monovalent cation induced structural transitions in telomeric DNAs: G-DNA folding intermediates. Biochemistry 30:4460-4472.
23. Jin, R., K. J. Breslauer, R. A. Jones, and B. L. Gaffney. 1990. Tetraplex formation of a guanine-containing nanomeric DNA fragment. Science 250: 543-546.
24. Kimura, Y., K. Sonehara, E. Kuramoto, T. Makino, T. Yamamoto, T. Kataoka, and T. Tokunaga. 1994. Binding of oligoguanylate to scavenger receptor is required for oligonucleotides to augment NK cell activity and induce IFN. J. Biochem. 116:991-994.
25. Lemaitre, M., B. Bayard, and B. Lebleu. 1987. Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site. Proc. Natl. Acad. Sci. USA 84:648-652.
26. Letsinger, R. L., G. Zhang, D. K. Sun, T. Ikeuchi, and P. S. Sarin. 1989. Cholesteryl conjugated oligonucleotides: synthesis, properties and activity as inhibitors of replication of human immunodeficiency virus in cell culture. Proc. Natl. Acad. Sci. USA 86:6553-6556.
27. Lewis, J. G., K. Y. Lin, A. Kothavale, W. M. Flanagan, M. D. Matteueci, R. B. DePrince, R. A. Mook, Jr., R. W. Hendren, and R. W. Wagner. 1996. A serum resistant cytofectin for cellular delivery of antisense oligonucleotides and plasmid DNA. Proc. Natl. Acad. Sci. USA 93:3176-3181.
28. Loke, S. L., C. A. Stein, X. H. Zhang, K. Mori, M. Nakanishi, C. Subasinghe, J. S. Cohen, and L. M. Neckers. 1989. Characterization of oligonucleotide transport into living cells. Proc. Natl. Acad. Sci. USA 86:3474-3478.
29. Lu, M., Q. Guo, and N. R. Kallenbach. 1992. Structure and stability of sodium and potassium complexes of dT4G4 and dT4G4T. Biochemistry 31:2455-2459.
30. Majumdar, S., and S. K. Basu. 1991. Killing of Mycobacterium tuberculosis by receptor-mediated drug delivery. Antimicrob. Agents Chemother. 35:135-140.
31. Mukhopadhyay, A., B. Mukhopadhyay, and S. K. Basu. 1995. Circumvention of multidrug resistance in neoplastic cells through scavenger receptor-mediated drug delivery. FEBS Lett. 376:95-98.
32. Mukhopadhyay, A., B. Mukhopadhyay, R. K. Srivastava, and S. K. Basu. 1992. Scavenger receptor mediated delivery of daunamycin elicits selective toxicity towards neoplastic cells of macrophage lineage. Biochem. J. 284: 237-241.
33. Mukhopadhyay, A., G. Chaudhuri, S. K. Arora, S. Sehgal, and S. K. Basu. 1989. Receptor mediated delivery to macrophages in chemotherapy of leishmaniasis. Science 244:705-707.
34. Mukhopadhyay, B., A. Mukhopadhyay, and S. K. Basu. 1993. Enhancement of tumoricidal activity of daunomycin by receptor mediated delivery: in vivo studies. Biochem. Pharmacol. 46:919-924.
35. Ojwang, J., A. Elbaggari, H. B. Marshall, K. Jayaraman, M. S. McGarth, and R. F. Rando. 1994. Inhibition of human immunodeficiency virus type I activity in vitro by oligonucleotides composed entirely of guanosine and thymidine. J. Acquired Immune Defic. Syndr. 7:560-570.
36. Pearson, A. M., A. Rich, and M. Krieger. 1993. Polynucleotide binding to macrophage scavenger receptors depends on the formation of base-quartet stabilized four stranded helices. J. Biol. Chem. 268:3546-3554.
37. Perez, R. R., L. Yuling, C. A. Stein, S. Majumdar, A. V. Oorschot, and R. Nararanan. 1994. Sequence independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA 91:5957-5961.
38. Probst, J. C., and T. Skutella. 1996. G-tetrads in antisense targeting. Trends Genet 12:290-291.
39. Rappaport, J., B. Hans, J. B. Kopp, T. D. Copeland, I. A. Bruggeman, T. M. Coffman, and P. E. Klotman. 1995. Transport of phosphorothioate oligonucleotides in kidney: implications for molecular therapy. Kidney Int. 47:1462-1469.
40. Rojanasakul, Y. 1996. Antisense oligonucleotide therapeutics: drug delivery and targeting. Adv. Drug Delivery Rev. 18:115-131.
41. Saxena, S. K., and E. J. Ackerman. 1990. Microinjected oligonucleotides complementary to the α-sarcin loop of the 28 S RNA abolish protein synthesis in xenopus oocyte. J. Biol. Chem. 265:3263-3269.
42. Shea, R. G., J. C. Marsters, and N. Bischolberger. 1990. Synthesis, hybridization properties and antiviral activity of lipid-oligodeoxynucleotide conjugates. Nucleic Acids Res. 18:3777-3783.
43. Stein, C. A. 1996. Phosphorothioate oligodeoxyribonucleotides: questions of specificity. Trends Biotechnol. 14:147-149.
44. Stein, C. A., and Y. C. Cheng. 1993. Antisense oligonucleotides as therapeutic agents-is the bullet really magical? Science 261:1004-1012.
45. Tackas, A. M., and A. K. Banerjee. 1997. Inhibition of vesicular stomatitis virus in cells constitutivery expressing an antisense RNA targeted against the virus RNA polymerase gene. J. Gen. Virol. 78:125-130.
46. Tang, J. Y., J. Temsamani, and S. Agrawal. 1993. Self-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activity. Nucleic Acids Res. 212729-2735.
47. Tolou, H. 1993. Administration of oligonucleotides to cultured cells by calcium phosphate precipitation method. Anal. Biochem. 215:156-158.
48. Tookinson, J. L., and C. A. Stein. 1994. Patterns of intracellular compartmentalization, trafficking and acidification of 5′ fluorescein labelled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells. Nucleic Acids Res. 22:4268-4275.
49. Wagner, E., M. Zenke, M. Gotten, H. Beug, and M. L. Birnstiel. 1990. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc. Natl. Acad. Sci. USA 87:3410-3414.
50. Wu, G. Y., and C. H. Wu. 1992. Specific inhibition of hepatitis B viral gene expression in vitro by targeted antisense oligonucleotides. J. Biol. Chem. 267:12436-12439.
51. Yakubov, L. A., E. A. Deeva, V. F. Zatytova, E. M. Ivanova, A. S. Ryte, L. V. Yurchenko, and V. V. Vlassov. 1989. Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc. Natl. Acad. Sci. USA 86:6454-6458.
52. Zelphati, O., J. L. Imbach, N. Signoret, G. Zon, B. Rayner, and L. Leserman. 1994. Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-I by several different mechanisms. Nucleic Acids Res. 22:4307-4314.